Literature DB >> 19496902

Cerebral embolism of iodized oil (lipiodol) after transcatheter arterial chemoembolization for hepatocellular carcinoma.

Joon-Tae Kim1, Suk-Hee Heo, Seong-Min Choi, Seung-Han Lee, Man-Seok Park, Byeong-Chae Kim, Yosik Kim, Myeong-Kyu Kim, Ki-Hyun Cho.   

Abstract

Cerebral lipiodol embolism is a rare complication of transcatheter arterial chemoembolization (TACE). Its pathological mechanism remains ambiguous despite several investigations. In Case 1, a 67-year-old man with hepatocellular carcinoma (HCC) experienced neurological deficits soon after undergoing a fourth session of TACE. Computed tomography (CT) scan showed multiple hyperdense lesions along the gyrus of frontal lobes and in the subcortical white matter. Transcranial Doppler (TCD) and transesophageal echocardiogram performed during the intravenous injection of agitated saline documented the presence of a right-to-left shunt (RLS) by demonstrating microbubbles in the left middle cerebral artery and left atrium. In Case 2, a 63-year-old woman underwent a third TACE due to a large HCC. After the procedure, her mental status deteriorated. Brain CT showed multiple hyperdense lesions on the cerebral and cerebellar cortex. TCD with agitated saline showed multiple microembolic signals shortly after the injection of agitated saline. The risk of cerebral lipiodol embolism may increase with recurrence and progression of HCC in patients who have a pre-existing RLS in the heart or lung. A test for the detection of an RLS may be necessary to identify patients with a heightened risk of cerebral embolism when multiple TACE procedures are required. TACE for HCC can cause pulmonary embolism or infarction.(1,2) However, cerebral lipiodol embolism is rare after TACE. There have been several reports of cerebral embolism after TACE, but their exact mechanism has not yet been fully elucidated. We report herein 2 patients who developed cerebral lipiodol embolism after undergoing multiple TACE procedures for remnant HCC through a pre-existing RLS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19496902     DOI: 10.1111/j.1552-6569.2009.00380.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  7 in total

Review 1.  Cerebral lipiodol embolism following transcatheter arterial chemoembolization for hepatocellular carcinoma.

Authors:  Lu Wu; Ye-Fa Yang; Jun Liang; Shu-Qun Shen; Nai-Jian Ge; Meng-Chao Wu
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

2.  Liposomes coloaded with iopamidol/lipiodol as a RES-targeted contrast agent for computed tomography imaging.

Authors:  Soonjae Kweon; Ho-Joon Lee; Woo Jin Hyung; Jinsuk Suh; Joon Seok Lim; Soo-Jeong Lim
Journal:  Pharm Res       Date:  2010-04-28       Impact factor: 4.200

3.  Utility of low-dose gelatin sponge particles and 5% ethanolamine oleate iopamidol mixture in retrograde transvenous obliteration (GERTO) for gastric varices.

Authors:  Atsushi Jogo; Akira Yamamoto; Toshio Kaminoh; Mariko Nakano; Ken Kageyama; Etsuji Sohgawa; Shinichi Hamamoto; Yukimasa Sakai; Masao Hamuro; Norifumi Nishida; Yukio Miki
Journal:  Br J Radiol       Date:  2020-02-14       Impact factor: 3.039

4.  Cerebral Lipiodol Embolism in Hepatocellular Carcinoma Patients Treated with Transarterial Embolization/Chemoembolization.

Authors:  Hai-Jui Chu; Chung-Wei Lee; Shin-Joe Yeh; Li-Kai Tsai; Sung-Chun Tang; Jiann-Shing Jeng
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

Review 5.  Cerebral lipiodol embolism related to a vascular lake during chemoembolization in hepatocellular carcinoma: A case report and review of the literature.

Authors:  Hideki Ishimaru; Minoru Morikawa; Takayuki Sakugawa; Ichiro Sakamoto; Yasuhide Motoyoshi; Yohei Ikebe; Masataka Uetani
Journal:  World J Gastroenterol       Date:  2018-10-07       Impact factor: 5.742

Review 6.  Intraarterial Therapies for the Management of Hepatocellular Carcinoma.

Authors:  Tushar Garg; Apurva Shrigiriwar; Peiman Habibollahi; Mircea Cristescu; Robert P Liddell; Julius Chapiro; Peter Inglis; Juan C Camacho; Nariman Nezami
Journal:  Cancers (Basel)       Date:  2022-07-10       Impact factor: 6.575

7.  Transcatheter Arterial Embolization Alone for Giant Hepatic Hemangioma.

Authors:  Jun-Hui Sun; Chun-Hui Nie; Yue-Lin Zhang; Guan-Hui Zhou; Jing Ai; Tan-Yang Zhou; Tong-Yin Zhu; Ai-Bin Zhang; Wei-Lin Wang; Shu-Sen Zheng
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.